{"disease":{"id":"abiraterone","name":"abiraterone"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06768255","title":"Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Ding-Wei Ye","has_results":false},{"nct_id":"NCT03449719","title":"Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":174,"lead_sponsor_name":"Lorenzo Livi","has_results":false},{"nct_id":"NCT04992026","title":"The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT04735913","title":"Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":81,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT06500247","title":"Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":43,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}